IXHL
Incannex Healthcare Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$3.25
−0.15%Next report
Analyst consensus
- Next report date
- Sep 4, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $200.0K
Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.60
- Revenue actual
- —
- Revenue estimate
- $200.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +18.6%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026